Head-to-head · WeighScore
PepHaūs vs Piper
By GLP-1 ScorecardUpdated
Score comparison
PepHaūs has the higher recorded score — 82.7/100 to 81.9/100, but only just.
PepHaūs grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Compare monthly billing with prepaid commitments, then confirm renewal pricing and supply. Piper is close behind and may still be the better fit — see the factor split below.
Before you choose
Before comparing the headline prices, the PepHaūs review and the Piper review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, PepHaūs vs PlexusDx and Piper vs Precision Telemed compare each of them with another graded program, and the list of alternatives to PepHaūs ranks the programs closest to PepHaūs on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Gala Health review covers one graded close to these two, at 82.9/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | PepHaūs | Piper |
|---|---|---|
| WeighScore | 82.7/100 | 81.9/100 |
| Grade | B− | B− |
| Site position | #25 | #29 |
| Semaglutide | $169 monthly; prepaid plans available (advertised) | $179 monthly; $135/month equivalent with six months prepaid. |
| Tirzepatide | $239 monthly; prepaid plans available (advertised) | $279/mo month-to-month; $199/mo equivalent requires six months and $1,194 prepaid. |
| Coverage | Claims all 50 states plus DC; treatment eligibility requires confirmation | All-state access claimed; confirm individual eligibility. |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Publishes monthly and prepaid plan amounts
- Names provider and pharmacy partners
What to consider
- Price-lock wording needs reconciling with renewal terms
- Actual supply and longer-plan shipments remain unverified
- Independent license and certification status remain unverified
Strengths
- Price FAQs distinguish monthly and prepaid plans.
- All-state access is advertised; individual eligibility needs confirmation.
- Advertises compounded injectable semaglutide and tirzepatide.
What to consider
- Assigned clinicians and dispensing facilities need confirmation.
- Refund cutoffs differ across public pages.
- Confirm the selected monitoring, billing and supply schedule.
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.